Hao Liang
- Cancer Research top 10%
- Cancer-related molecular mechanisms research 9
- Molecular Biology top 10%
- CRISPR and Genetic Engineering 9
- RNA Research and Splicing 7
- Pluripotent Stem Cells Research 6
- Epigenetics and DNA Methylation 6
- Biochemistry top 10%
- Urology top 10%
-
- Animal Genetics and Reproduction 12
- Mesenchymal stem cell research 7
-
- Nanoparticles: synthesis and applications 6
Hao Liang
89 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 124
- Cancer Research 290
- Molecular Biology 774
- Biochemistry 60
- Urology 52
- Aging 13
Countries citing papers authored by Hao Liang
This map shows the geographic impact of Hao Liang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hao Liang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hao Liang more than expected).
Fields of papers citing papers by Hao Liang
This network shows the impact of papers produced by Hao Liang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hao Liang. The network helps show where Hao Liang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Hao Liang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 28 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 6 | |
| 5 | 2024 | 1 | |
| 6 | 2024 | 0 | |
| 7 | 2024 | 14 | |
| 8 | 2024 | 8 | |
| 9 | 2023 | 16 | |
| 10 | 2022 | 4 | |
| 11 | 2022 | 65 | |
| 12 | 2021 | 5 | |
| 13 | 2021 | 22 | |
| 14 | 2021 | 6 | |
| 15 | 2020 | 112 | |
| 16 | 2020 | 18 | |
| 17 | 2016 | 2 | |
| 18 | 2015 | 13 | |
| 19 | 2015 | 3 | |
| 20 | 2012 | 22 |
About Hao Liang
Hao Liang is a scholar working on Cancer Research, Biochemistry and Molecular Biology, having authored 93 papers that have together received 1.5k indexed citations. Recurring topics across this work include Animal Genetics and Reproduction (12 papers), CRISPR and Genetic Engineering (9 papers), Cancer-related molecular mechanisms research (9 papers), Mesenchymal stem cell research (7 papers), RNA Research and Splicing (7 papers), Nanoparticles: synthesis and applications (6 papers), Pluripotent Stem Cells Research (6 papers) and Epigenetics and DNA Methylation (6 papers). The work is most often cited by research in Cancer Research (290 citations), Molecular Biology (774 citations) and Biochemistry (60 citations). Hao Liang has collaborated with scholars based in China, Japan and Mongolia. Frequent co-authors include Yan Cheng, Yanwei Xu, Dongjun Liu, Yi Pan, Ming Cang, Yongji Yang, Fude Wang, Huaiyu Qiao, Jingyi Jiang and Bao-Qin Liu. Their work appears in journals such as Journal of the American Chemical Society, Angewandte Chemie International Edition and Journal of the American College of Cardiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.